<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03561337</url>
  </required_header>
  <id_info>
    <org_study_id>AURunners2017</org_study_id>
    <nct_id>NCT03561337</nct_id>
  </id_info>
  <brief_title>Nutrient Supplementation Influences Mitochondria Adaptation</brief_title>
  <official_title>Effect of Whey Protein Hydrolysate on Adaptions to Endurance Training in Well-trained Runners</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Twenty-four well trained runners (VO2max 60.73.7 ml O2 Kg-1 min1) completed a six week block
      randomized controlled intervention period. Subjects were randomly assigned to either PRO-CHO
      or CHO and matched in pairs for gender, age, VO2max, training and performance status. The
      PRO- CHO group ingested a protein beverage (0.3g kg-1) before and protein-carbohydrate
      beverage (0.3g protein kg-1 and 0.1g carbohydrate kg-1) after each exercise session. The CHO
      group ingested energy matched carbohydrate. Post-absorptive muscle biopsies were obtained pre
      and post intervention for analysis HAD, CS and PGC-1. Subjects completed two physical tests 6
      km performance test (pre, week 1 and week 6) and aVo2max test (pre and post intervention).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2013</start_date>
  <completion_date type="Actual">June 1, 2014</completion_date>
  <primary_completion_date type="Actual">February 1, 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>block randomized controlled intervention</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Single blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal oxygen uptake</measure>
    <time_frame>Change from week 1 to week 6</time_frame>
    <description>maximal oxygen uptake (L O2/min)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>VDAC</measure>
    <time_frame>Change from week 1 to week 6</time_frame>
    <description>Mitochondria target measured by western blotting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CytC</measure>
    <time_frame>Change from week 1 to week 6</time_frame>
    <description>Mitochondria enzyme measured by western blotting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance</measure>
    <time_frame>Change from week 1 to week 6</time_frame>
    <description>6 km trial test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>COX-IV</measure>
    <time_frame>Change from week 1 to week 6</time_frame>
    <description>Mitochondria target measured by western blotting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HSP60</measure>
    <time_frame>Change from week 1 to week 6</time_frame>
    <description>Mitochondria target measured by western blotting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CD36</measure>
    <time_frame>Change from week 1 to week 6</time_frame>
    <description>Fat transporter measured by western blotting</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Performance</condition>
  <condition>Nutrition</condition>
  <condition>Protein</condition>
  <arm_group>
    <arm_group_label>PROTEIN-CARBOHYDRATE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention group receiving protein and carbohydrate supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CARBOHYDRATE</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intervention groups receiving carbohydrate supplement</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>PROTEIN-CARBOHYDRATE</intervention_name>
    <description>PRO before and PRO-CHO after training</description>
    <arm_group_label>PROTEIN-CARBOHYDRATE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>CARBOHDYRATE</intervention_name>
    <description>CHO before and after training</description>
    <arm_group_label>CARBOHYDRATE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. maximal oxygen uptake (VO2max) of &gt;50ml O2 kg-1 min-1 for women and &gt;55ml O2 kg-1
             min-1 for men,

          2. running at least 3 times a week and

          3. running being the primarily training form

        Exclusion Criteria:

          1. use of medicine

          2. diagnosed metabolic diseases

          3. injuries which hindered running and body mass index (BMI) &lt; 25 kg m-2
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Aarhus University, Department for Public Health, Section for Sport Science</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sport Science, Department of Public Health, Aarhus University</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>December 1, 2017</study_first_submitted>
  <study_first_submitted_qc>June 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2018</study_first_posted>
  <last_update_submitted>May 12, 2020</last_update_submitted>
  <last_update_submitted_qc>May 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Aarhus</investigator_affiliation>
    <investigator_full_name>Mette Hansen</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

